Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:INISNASDAQ:KEQUNASDAQ:NAUTNASDAQ:ODYS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINISInternational Isotopes$0.05-0.6%$0.05$0.03▼$0.06$26.74M0.6475,288 shs7,000 shsKEQUKewaunee Scientific$39.010.0%$35.74$30.33▼$71.33$111.36M0.4723,894 shs4,932 shsNAUTNautilus Biotechnology$0.76+2.5%$0.78$0.66▼$3.09$96.00M1.41118,281 shs110,722 shsODYSOdysight.Ai$5.27-1.5%$5.69$5.01▼$10.80$85.99M0.6424,166 shs5,564 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINISInternational Isotopes-0.59%+2.63%+27.00%+20.67%+30.26%KEQUKewaunee Scientific+1.22%+8.48%+19.11%-28.68%-2.23%NAUTNautilus Biotechnology-3.95%-5.37%+9.19%-36.54%-71.22%ODYSOdysight.Ai+0.19%+1.33%-1.47%-17.57%+534,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINISInternational IsotopesN/AN/AN/AN/AN/AN/AN/AN/AKEQUKewaunee Scientific1.8829 of 5 stars0.03.00.80.02.72.51.3NAUTNautilus Biotechnology2.4704 of 5 stars3.02.00.00.02.24.20.6ODYSOdysight.Ai1.8582 of 5 stars3.50.00.00.03.40.80.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINISInternational Isotopes 0.00N/AN/AN/AKEQUKewaunee Scientific 0.00N/AN/AN/ANAUTNautilus Biotechnology 2.00Hold$2.42217.56% UpsideODYSOdysight.Ai 3.00Buy$10.0089.75% UpsideCurrent Analyst Ratings BreakdownLatest INIS, KEQU, NAUT, and ODYS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/2/2025ODYSOdysight.AiBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.002/28/2025NAUTNautilus BiotechnologyGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$2.50(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINISInternational Isotopes$12.27M2.18N/AN/A$0.01 per share5.08KEQUKewaunee Scientific$220.03M0.51$0.86 per share45.30$13.60 per share2.87NAUTNautilus BiotechnologyN/AN/AN/AN/A$2.12 per shareN/AODYSOdysight.Ai$5.84M14.72N/AN/A$1.71 per share3.08Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINISInternational Isotopes-$870KN/A0.00∞N/A-2.63%-8.68%-2.09%8/12/2025 (Estimated)KEQUKewaunee Scientific$18.75M$5.916.18∞N/A9.39%25.83%10.75%6/25/2025 (Estimated)NAUTNautilus Biotechnology-$63.67M-$0.54N/AN/AN/AN/A-28.85%-24.93%7/29/2025 (Estimated)ODYSOdysight.Ai-$9.44M-$1.02N/A∞N/A-207.38%-56.78%-43.36%N/ALatest INIS, KEQU, NAUT, and ODYS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025ODYSOdysight.AiN/A-$0.29N/A-$0.29N/A$2.07 million4/29/2025Q1 2025NAUTNautilus Biotechnology-$0.14-$0.13+$0.01-$0.13N/AN/A3/26/2025Q4 2024ODYSOdysight.AiN/A-$0.29N/A-$0.29N/A$1.30 million3/12/2025Q3 2025KEQUKewaunee ScientificN/A$1.09N/A$0.45N/A$67.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINISInternational IsotopesN/AN/AN/AN/AN/AKEQUKewaunee Scientific$0.761.95%N/A12.86%N/ANAUTNautilus BiotechnologyN/AN/AN/AN/AN/AODYSOdysight.AiN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINISInternational Isotopes0.441.581.33KEQUKewaunee Scientific0.452.642.13NAUTNautilus BiotechnologyN/A16.6516.65ODYSOdysight.AiN/A7.907.79Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINISInternational IsotopesN/AKEQUKewaunee Scientific32.69%NAUTNautilus Biotechnology50.71%ODYSOdysight.Ai19.67%Insider OwnershipCompanyInsider OwnershipINISInternational Isotopes15.60%KEQUKewaunee Scientific14.20%NAUTNautilus Biotechnology41.10%ODYSOdysight.AiN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINISInternational Isotopes30526.39 million442.01 millionNot OptionableKEQUKewaunee Scientific8902.86 million2.46 millionNot OptionableNAUTNautilus Biotechnology130126.15 million74.71 millionOptionableODYSOdysight.Ai4016.32 millionN/AN/AINIS, KEQU, NAUT, and ODYS HeadlinesRecent News About These CompaniesY.D. More Investments Ltd Sells 8,600 Shares of Odysight.Ai Inc. (NASDAQ:ODYS) StockMay 23, 2025 | marketbeat.comInsider Selling: Odysight.Ai Inc. (NASDAQ:ODYS) Major Shareholder Sells 8,600 Shares of StockMay 22, 2025 | insidertrades.comOdysight.ai Reports Financial Results for The First Quarter of 2025 and Provides Business UpdateMay 15, 2025 | globenewswire.comOdysight.ai to participate at MRO Americas 2025 - International trade fair in the Aerospace IndustryApril 2, 2025 | globenewswire.comOdysight.ai Reports Full Year 2024 Financial Results and Provides Business UpdateMarch 26, 2025 | globenewswire.comInsider Selling: Odysight.Ai Inc. (NASDAQ:ODYS) Major Shareholder Sells 2,400 Shares of StockMarch 14, 2025 | insidertrades.comOdysight.ai to Participate at the 37th Annual ROTH Conference on March 17-18, 2025March 3, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsNavitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookBy Leo Miller | May 27, 2025View Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookQualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongBy Sam Quirke | May 13, 2025View Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumAmer Sports: The New ONON and DECK of Consumer Discretionary?By Leo Miller | May 28, 2025View Amer Sports: The New ONON and DECK of Consumer Discretionary?INIS, KEQU, NAUT, and ODYS Company DescriptionsInternational Isotopes OTCMKTS:INIS$0.05 0.00 (-0.59%) As of 05/28/2025 03:20 PM EasternInternational Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through four segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. This segment also offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. The company sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.Kewaunee Scientific NASDAQ:KEQU$39.01 -0.01 (-0.01%) As of 02:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.Nautilus Biotechnology NASDAQ:NAUT$0.76 +0.02 (+2.49%) As of 03:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.Odysight.Ai NASDAQ:ODYS$5.27 -0.08 (-1.50%) As of 01:47 PM EasternOdysight.ai, Inc. engages in the development and manufacture of customized visual solutions for organizations across a variety of industries in the form of micro cameras and supplementary technologies. Its devices can used across the medical, aerospace, industrial, research, and defense industries. The company was founded on March 22, 2013 and is headquartered in Omer, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Intel's Loss Is Broadcom's Gain as AVGO Dominates Networking Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
